Method for screening aptamer via high performance liquid chromatography, aptamer and application
A high-performance liquid chromatography and nucleic acid aptamer technology, which can be used in pharmaceutical formulations, medical preparations with inactive ingredients, and medical preparations containing active ingredients, etc., and can solve the problems of difficulty in automation, high cost, and low efficiency. , to achieve the effect of low instrument requirements, low cost and strong universality
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0048] Example 1:
[0049] A method for HPLC-assisted screening of nucleic acid aptamers, mainly using microfluidic chips for screening, and the specific screening process includes the following steps:
[0050] (a) Optimize the nucleic acid library: The structure of the DNA library is divided into five parts: the middle is a 26-base fixed sequence for complementary hybridization with the fixed probe (BDNA); the fixed sequence is flanked by two DNA arms, Both include a random sequence of 18 bases and a sequence necessary for PCR amplification of 19 bases. The immobilized probe is a DNA strand that is labeled with biotin at one end and is complementary to the immobilized sequence of the library, and is used for immobilization of the library.
[0051] The random library RS36 has the nucleotide sequence described in SEQ ID NO. 1, specifically:
[0052] 5'-CCGCTTCGCCGTCTCCTAC-NNNNNNNNNNNNNNNNNN-AAAAGTGGGTAGGGCGGGTTGGAAAA-NNNNNNNNNNNNNNNNNNNN-CGCTCGTCACCCTTCTCCT-3' (Note: N represents any ...
Example Embodiment
[0070] Example 2
[0071] A nucleic acid aptamer 1 of docetaxel obtained by the method of Example 1. The nucleotide sequence of the nucleic acid aptamer 1 has the nucleotide sequence described in SEQ ID NO. 2, specifically 5'- TTGTTTCTCTGTCGATTA-3'.
Example Embodiment
[0072] Example 3
[0073] A nucleic acid aptamer 2 of docetaxel screened by the method of Example 1. The nucleotide sequence of the nucleic acid aptamer 2 has the nucleotide sequence described in SEQ ID NO. 3, specifically 5'- ATTAGCTGTCTCTTTGTT-3'.
[0074] The nucleotide sequences of the nucleic acid aptamers of Example 2 and Example 3 are selected from naturally occurring or artificially synthesized sequences, or the same sequences from any other source.
[0075] Examples 2 and 3 are only the preferred nucleic acid aptamers screened in the present invention. According to the screening method of the present invention, nucleic acid aptamers with the following nucleotide sequences can also be screened:
[0076] (1) The homology with the nucleotide sequence of the nucleic acid aptamer listed in Example 2 or 3 is above 60% (for example, the sequence of the nucleic acid aptamer can be deleted or partially complementary nucleotides can be added);
[0077] (2) A sequence that hybridizes wit...
PUM
Property | Measurement | Unit |
---|---|---|
Solubility | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap